Clinical Trials Browser

Phase 2/3 × Thyroid Neoplasms × Dexmedetomidine × Clear all

NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

Phase 2/3 Active not recruiting

Thyroid Neoplasms